Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections
05. Oktober 2023 09:00 ET | Exbaq LLC
Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and FungiVaccine provides protection against infections within 24hours and protection lasts for up to...
Tenaya_Logo_FullColor-RGB.jpg
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure
06. Juli 2022 14:00 ET | Tenaya Therapeutics, Inc.
Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms Tenaya’s HDAC6 Inhibitor TN-301 Advancing to the Clinic for HFpEF, with...
faculty_SternJ
Hofstra North Shore-LIJ School of Medicine Professor Publishes Pivotal MS Study
08. August 2014 13:17 ET | North Shore Long Island Jewish Health System
HEMPSTEAD, N.Y., Aug. 8, 2014 (GLOBE NEWSWIRE) -- A Hofstra North Shore-LIJ School of Medicine professor has published breakthrough research that pinpoints the origin of the cell that is alleged to...